ALNYLAM PHARMACEUTICALS, INC.: accounts_receivable

Value{"amount": 353852000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2024-09-30)
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-24-000053
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/accounts-receivable/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/28cfba30-7ed1-4b7a-ad11-c0dc885742e1

History